Patient Timeline & Presentation
5 months
0 mo (Immediate) 6 mo (Rebound peak) 12 mo (Endocrine baseline) 18 mo
Endocrine Evaluation & Differential Analysis Rotterdam Diagnostic Framework
Active transition window (5 months < 12 months) Requires Clinical Follow-up: Yes
Post-Pill Endocrine Window 5 mo: Natural Androgen Surge & HPO Reset
0m: Acute Withdrawal 3-9m: Sebaceous/Androgen Peak 12m+: Persistent Threshold
Rotterdam PCOS Consensus Criteria Check 2 of 3 Criteria Met

Clinical consensus requires at least 2 out of 3 features after excluding thyroid dysfunction, hyperprolactinemia, or non-classical CAH:

1. Ovulatory Dysfunction / Oligomenorrhea: Present (2-3 periods in 5 months off pill).
2. Hyperandrogenism (Clinical or Biochemical): Present (Jawline breakouts, chin/facial hair darkening, thigh hair changes).
?
3. Polycystic Ovarian Morphology (Ultrasound / AMH): Unverified (Requires pelvic ultrasound: ≥20 follicles/ovary or increased ovarian volume >10ml).
⚠️
Differential Red Flags Detected: Substantial unexplained weight loss (-2 stone) and daily chronic abdominal pain are NOT standard post-pill withdrawal or typical PCOS features. They warrant prioritized gastroenterological / comprehensive medical evaluation to exclude IBD, celiac disease, or chronic pelvic pain etiology.

Recommended Evidence-Based Action Items

  • Track basal body temperature or ovulation strips if trying to verify cycle resumption
  • Log duration and exact characteristics of facial and body hair changes
  • Discuss persistent weight loss and abdominal pain separately with a physician
  • Schedule hormone panel (total/free testosterone, DHEAS, LH/FSH) after month 6 if cycles remain irregular
Primary diagnostic benchmark: 2023 International Evidence-based Guideline for PCOS & Rotterdam Consensus Criteria. Hormonal birth control suppresses LH/FSH and masks pre-existing oligomenorrhea for the duration of therapy.
Enjoy this tool? Build your own with Super